| Entry |
|
|---|
| Name |
Trafermin (USAN/INN);
Trafermin (genetical recombination) (JAN);
Fiblast (TN) |
|---|
| Formula |
C764H1201N217O219S6
|
|---|
| Exact mass |
17111.7836
|
|---|
| Mol weight |
17122.4232
|
|---|
| Remark |
|
|---|
| Efficacy |
Anti-ulcerative (skin), Periodontal guided tissue regeneraion agent, Stroke treatment |
|---|
| Comment |
Fibroblast growth factor
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
D DERMATOLOGICALS
D03 PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS
D03A CICATRIZANTS
D03AX Other cicatrizants
D03AX15 Trafermin
D03362 Trafermin (USAN/INN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
13 Agents affecting sensory organs
132 Otic and nasal agents
1329 Others
D03362 Trafermin (USAN/INN); Trafermin (genetical recombination) (JAN)
2 Agents affecting individual organs
26 Epidermides
269 Miscellaneous
2699 Others
D03362 Trafermin (USAN/INN); Trafermin (genetical recombination) (JAN)
27 Dental preparations
279 Miscellaneous
2790 Miscellaneous
D03362 Trafermin (USAN/INN); Trafermin (genetical recombination) (JAN)
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D03362
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
